Apparently the CEO resigned 10 days ago "for personal reasons with immediate effect".
October 6, 2021 at 2 PM Eastern/11 AM Pacific
SDN and Osmosis are teaming up to help you get set up for success this school year! We'll be covering study tips, healthy habits, and meeting mentors.
It's a defacto Monopoly now imo....We need a strong Elekta to counterbalance Varian. In the heyday of multiple linac manufacturers I remember having some "wiggle room" to negotiate...but now in my experience Varian is just like "meh, we know we're the best, not going to work with you here's the price."
It's a defacto Monopoly now imo....
Unfortunately i don't think it will be worth it, and it will just push Varian into an even more dominant market position for standard linac based radiation therapyIt appears to me that Elektas focus on the MRI Linac has pretty much absorbed all resources of the company so that development of their other "normal" LINACs and software (user friendliness!!!) was neglected in the past years.
It will surely pay off, if MR-guided radiotherapy will be proven essential to the point that every larger clinic would like to have one of those machines to treat certain indications.
Accuray did that to TomoTherapy inc after the stock had fallen 70-80% from the IPO...I'm just speculating here - but I'm pretty sure Varian is sitting back on the MR-linac space just to pounce on a company in financial trouble (ViewRay cough cough).
“Loophole? It’s standard of care in this space.” - Academic rad oncs, 2020
also cynically...I hope it does work because we need any kind of possible technological boon we can get as a field
I don’t see the appeal of mri guided radiation for most indications but i suppose if adapting it should be reimbursed right?
also cynically...I hope it does work because we need any kind of possible technological
boon we can get as a field
It'll get APM'd
Those planning charges aren't going to be here for long at all.
I don’t see the appeal of mri guided radiation for most indications